quinine sulphate tablets 300 mg
shelys pharmaceuticals limited, tanzania - quinine - tablets - 300 mg
quinine sulphate tablets 300 mg
remedica ltd, cyprus - quinine - tablets - 300 mg
quinine tablets 300mg oral solid ordinary other coated tablets
elys chemical industries ltd - quinine sulphate - oral solid ordinary other coated tablets - 300mg
quinine tablets
laboratory & allied ltd p.o box 42875 gpo 00100 nairobi kenya - quinine sulphate - tablet - 300mg per tablet - other antimalarial antiprotozoals
quinine mixture syrup
laboratory & allied ltd p.o box 42875 gpo 00100 nairobi kenya - quinine bisulphate - syrup - 50mg per 5ml - other antimalarial antiprotozoals
quinine sulfate capsule
riconpharma llc - quinine sulfate (unii: kf7z0e0q2b) (quinine - unii:a7v27phc7a) - quinine sulfate 324 mg
quinine sulfate capsule
ingenus pharmaceuticals nj, llc - quinine sulfate (unii: kf7z0e0q2b) (quinine - unii:a7v27phc7a) - quinine sulfate 324 mg
quinine sulfate capsule
corepharma, llc - quinine sulfate (unii: kf7z0e0q2b) (quinine - unii:a7v27phc7a) - quinine sulfate 324 mg
quinine sulfate capsule
mylan pharmaceuticals inc. - quinine sulfate (unii: kf7z0e0q2b) (quinine - unii:a7v27phc7a) - quinine sulfate 324 mg
qualaquin- quinine sulfate capsule
sun pharmaceutical industries, inc. - quinine sulfate (unii: kf7z0e0q2b) (quinine - unii:a7v27phc7a) - quinine sulfate 324 mg - qualaquin is an antimalarial drug indicated only for treatment of uncomplicated plasmodium falciparum malaria. quinine sulfate has been shown to be effective in geographical regions where resistance to chloroquine has been documented [see clinical studies (14) ]. limitations of use: qualaquin is not approved for: qualaquin is contraindicated in patients with the following: risk summary prolonged experience with quinine in pregnant women over several decades, based on published prospective and retrospective observational studies, surveys, safety and efficacy studies, review articles, case reports and case series have not identified a drug associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes (see data) . in animal reproduction studies, administration of quinine by multiple routes of administration to pregnant rabbits, dogs, guinea pigs, rats, and monkeys during the period of organogenesis at doses of 0.25 to 2 times the maximum recommended human dose (mrhd) based on body su